Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children
Zuccotti, G.V.; Cucchi, C.; Sala, D.; Giovannini, M.
Acta Paediatrica 91(4): 486; Author Reply 487
2002
ISSN/ISBN: 0803-5253 PMID: 12061369 DOI: 10.1111/j.1651-2227.2002.tb01676.xDocument Number: 261401
Document emailed within 0-6 h
Related Documents
Zuccotti, G.V.; Cucchi, C.; Sala, D.; Giovannini, M. 2002: Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children Acta Paediatrica 91(4): 486; Author Reply 487Erofeeva, M.K.; Mel'nikov, S.I.; Semchenko, A.V.; Korovkin, S.A.; Nikonorov, I.I.; Maksakova, V.L.; Voĭtsekhovskaia, E.M.; Erman, E.S.; Gonchar, V.V.; Pozdeev, V.K.; Drinevskiĭ, V.P. 2010: Clinical trial of safety and immunogenicity of new influenza vaccine Grifor in children Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 55-59
Phongsamart, W.; Sirisanthana, V.; Wittawatmongkol, O.; Maleesatharn, A.; Sudjaritruk, T.; Chearskul, P.; Aurpibul, L.; Sirisanthana, T.; Chokephaibulkit, K. 2011: Immunogenicity and safety of monovalent influenza a (H1N1) 2009 in HIV-infected Thai children Vaccine 29(47): 8705-8711
Guo, W.; Xu, J.; Wu, J.; Zhao, S.; He, H.; Shi, W.; Yu, D.; Li, J.; Gao, H.; Chen, J. 2014: Safety and immunogenicity of seasonal inactivated influenza vaccine (split virion) and cross-reactive antibody responses to the H7N9 avian influenza virus Zhonghua Liu Xing Bing Xue Za Zhi 35(8): 949-952
Gatchalian, S.; Tabora, C.; Bermal, N.; Leboulleux, D.; Desauziers, E. 2004: Immunogenicity and safety of a varicella vaccine (Okavax) and a trivalent measles, mumps, and rubella vaccine (Trimovax) administered concomitantly in healthy Filipino children 12-24 months old American Journal of Tropical Medicine and Hygiene 70(3): 273-277
Lee, C.Y.; Huang, L.M.; Lee, P.I.; Chiu, H.H.; Dumas, R.; Milcamps, B.; Lin, W. 2000: Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children Southeast Asian Journal of Tropical Medicine and Public Health 31(1): 29-36
Simasathien, S.; Thomas, S.J.; Watanaveeradej, V.; Nisalak, A.; Barberousse, Célia.; Innis, B.L.; Sun, W.; Putnak, J.Robert.; Eckels, K.H.; Hutagalung, Y.; Gibbons, R.V.; Zhang, C.; De La Barrera, R.; Jarman, R.G.; Chawachalasai, W.; Mammen, M.P. 2008: Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children American Journal of Tropical Medicine and Hygiene 78(3): 426-433
Lehmann, D.; Kakazo, M.; Yarsley, S.; Javati, A.; Taime, J.; Saleu, G.; Namuigi, P.; Alpers, M.P.; Mendelman, P.M.; Staub, T. 1998: Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua new Guinean children Papua and new Guinea Medical Journal 41(3-4): 102-111
Lieberman, J.M.; Chiu, S.S.; Wong, V.K.; Partidge, S.; Chang, S.J.; Chiu, C.Y.; Gheesling, L.L.; Carlone, G.M.; Ward, J.I. 1996: Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial JAMA 275(19): 1499-1503
Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322
Vasil'eva, R.I.; Osidak, L.V.; Bichurina, M.A.; Mukhina, L.P.; Chudina, L.V. 1982: Evaluation of the safety, reactogenicity and antigenic activity of inactivated chromatographic influenza vaccine in school children Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 96-98
Berezin, V.E.; Zaĭdes, V.M.; Isaeva, E.S.; Zhdanov, V.M. 1985: Immunogenicity of a subunit influenza vaccine in experiments on animals Voprosy Virusologii 30(2): 166-174
Ryder, R.W.; Oxtoby, M.J.; Mvula, M.; Batter, V.; Baende, E.; Nsa, W.; Davachi, F.; Hassig, S.; Onorato, I.; Deforest, A. 1993: Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1 Journal of Pediatrics 122(5 Part 1): 697-702
Zhang, X.-g.; Li, K.-b.; Ma, J.; Wang, N.-f.; Zhang, X.-m.; Sang, Y.-h.; Dong, J.; Xu, H.; Zeng, Y. 2009: Study on the immunogenicity of adeno-vector vaccine against H5N1 influenza a virus Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(2): 97-99
Zhang, Z.-L.; Wang, X.; Zhu, X.-J.; Zhang, Y.; Liu, Y.; Gao, Z.-G.; Liang, M.; Li, L.; Li, J.-M.; Liu, R.-K.; Dong, X.-J.; Song, G.-X.; Zhang, D.-C.; Wang, W.-Q.; Han, Y.-G.; Chen, J.-T. 2009: Safety and immunogenicity on three lots of influenza split vaccines among adults Zhonghua Liu Xing Bing Xue Za Zhi 30(6): 583-587
Rymkiewicz, D.; Sawicki, J.; Wysokińska, T. 1992: Evaluation of safety and immunogenicity of the Td vaccine in laboratory studies Przeglad Epidemiologiczny 46(4): 325-327
Bitragunta, S.; Murhekar, M.V.; Chakravarti, A.; Verma, V.; Namjoshi, G.S.; Parekh, S.S.; Sharma, H.J.; Kumar, B.K.; Gupte, M.D. 2010: Safety and immunogenicity of single dose of tetanus-diphtheria (Td) vaccine among non/partially immune children against diphtheria and/or tetanus, Hyderabad, India, 2007 Vaccine 28(37): 5934-5938
Botet Asensi, F.I.; Veronese, A.; Del Carmen Otero, M.; Desamparados Tamarit Pérez, M.; Hontangas Lopez, J.L.; Viviani, S. 2003: Immunogenicity and safety in infants of a DTwPHib full liquid vaccine Acta Paediatrica 92(5): 541-545
Grigor'eva, E.P.; Desheva, I.A.; Donina, S.A.; Naĭkhin, A.N.; Rekstin, A.R.; Barantseva, I.B.; Zavitkova, E.A.; Moskvicheva, T.M.; Zhavoronkov, V.G.; Rudenko, L.G. 2002: The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years Voprosy Virusologii 47(4): 24-27
Huan, L-Fang.; Yao, L-Hong.; Chen, A-Jun.; Cheng, C-Sheng.; Jia, R-Qing.; Tian, Q.; Bo, H.; Guo, J-Qiang.; Wang, M.; Shu, Y-Long.; Zhang, Z-Qing. 2007: Construction and immunogenicity study of DNA vaccine expressing human H5N1 influenza virus hemagglutinin Bing du Xue Bao 23(5): 366-370